Stanley I. Rapoport
Rapoport, Stanley I.
Rapoport, Stanley I., 1932-
VIAF ID: 72036142 (Personal)
Permalink: http://viaf.org/viaf/72036142
Preferred Forms
-
- 100 1 _ ‡a Rapoport, Stanley I.
-
- 100 1 _ ‡a Rapoport, Stanley I.
- 100 1 _ ‡a Rapoport, Stanley I.
- 100 1 _ ‡a Rapoport, Stanley I.
- 100 1 0 ‡a Rapoport, Stanley I.
-
- 100 1 _ ‡a Rapoport, Stanley I. ‡d 1932-
-
- 100 0 _ ‡a Stanley I. Rapoport
4xx's: Alternate Name Forms (15)
Works
Title | Sources |
---|---|
[3H]Methotrexate loss from the rat brain following enhanced uptake by osmotic opening of the blood-brain barrier. | |
Alzheimer's : the disease of the century | |
Blood-brain barrier in physiology and medicine | |
Blood-brain barrier opening after explosive decompression from hyperbaric N2-O2 mixtures | |
Brain in aging and dementia, 1983: | |
Brain transfer coefficients for 67Ga: comparison to 55Fe and effect of calcium deficiency. | |
Chronic exposure of neural cells to elevated intracellular sodium decreases mitochondrial mRNA expression. | |
Chronic fluoxetine increases cytosolic phospholipase A | |
Chronic fluoxetine upregulates arachidonic acid incorporation into the brain of unanesthetized rats | |
Chronic lithium administration potentiates brain arachidonic acid signaling at rest and during cholinergic activation in awake rats | |
Chronic lithium chloride administration to rats decreases brain protein level of epsilon (epsilon) subunit of eukaryotic initiation factor-2B | |
Chronic lithium chloride administration to rats elevates glucose metabolism in wide areas of brain, while potentiating negative effects on metabolism of dopamine D2-like receptor stimulation | |
Chronic lithium feeding reduces upregulated brain arachidonic acid metabolism in HIV-1 transgenic rat. | |
Chronic NMDA administration increases neuroinflammatory markers in rat frontal cortex: cross-talk between excitotoxicity and neuroinflammation | |
Chronic NMDA administration to rats up-regulates frontal cortex cytosolic phospholipase A2 and its transcription factor, activator protein-2. | |
Chronic nutritional deprivation of n-3 alpha-linolenic acid does not affect n-6 arachidonic acid recycling within brain phospholipids of awake rats | |
Chronic treatment of rats with sodium valproate downregulates frontal cortex NF-kappaB DNA binding activity and COX-2 mRNA | |
Chronic treatment with mood stabilizers increases membrane GRK3 in rat frontal cortex | |
Chronic valproate treatment blocks D2-like receptor-mediated brain signaling via arachidonic acid in rats | |
Chronic valproate treatment decreases the in vivo turnover of arachidonic acid in brain phospholipids: a possible common effect of mood stabilizers | |
Chronobiological aspects of studying the cardiovascular system | |
[Chronomedicine: its achievements and objectives] | |
[Chymotrypsin activity in various pH values] | |
[Circadian rhythms of psychophysiological functions in gastric peptic ulcer patients] | |
[Classification of the cellular changes in the gastric mucosa] | |
Clinical aspects, diagnosis and treatment of an uncomplicated peptic ulcer of the stomach | |
[Clinical aspects of multiple metastases of thyroid cancer] | |
Clinical history, brain metabolism, and neuropsychological function in Alzheimer's disease | |
Clinical pharmacokinetics of arecoline in subjects with Alzheimer's disease. | |
Clinical significance of gastric acidity determination | |
[Clinico-experimental parallels of the enzyme diagnosis of chronic pancreatitis (Moscow)] | |
Co-localization of cytosolic phospholipase A2 and cyclooxygenase-2 in Rhesus monkey cerebellum | |
Coenzyme A and short-chain acyl-CoA species in control and ischemic rat brain | |
Combined immunochemical and electrophoretic determinations of proteins in paired serum and cerebrospinal fluid samples | |
Comparative estimation of biocontrolled endoscopic and transcutaneous laser therapy of ulcer | |
Comparative inhibitory effects of various physostigmine analogs against acetyl- and butyrylcholinesterases | |
Comparison of positron emission tomography, cognition, and brain volume in Alzheimer's disease with and without severe abnormalities of white matter | |
Computed tomographic analysis of brain morphometrics in 30 healthy men, aged 21 to 81 years | |
Computer-assisted categorization of brain computerized tomography pixels into cerebrospinal fluid, white matter, and gray matter | |
Contrast media: quantitative criteria for designing compounds with low toxicity | |
Convection, diffusion, and electric current through a membrane | |
Coordination of gene expression of arachidonic and docosahexaenoic acid cascade enzymes during human brain development and aging | |
Corpus callosum atrophy is a possible indicator of region- and cell type-specific neuronal degeneration in Alzheimer disease: a magnetic resonance imaging analysis | |
The cortical acidic response to intravenous NaHCO 3 and the nature of blood brain barrier damage | |
[A cytofluorometric study of DNA concentration in superficial epithelial cells of the mucous membrane of the stomach in ulcer disease and cancer] | |
A fine structural study of the hippocampus and dorsal root ganglion in mouse trisomy 16, a model of Down's syndrome | |
A Fixed Charge Model of the Transverse Tubular System of Frog Sartorius | |
Imaging, cerebral topography, and Alzheimer's disease, c1990: | |
Imaging decreased brain docosahexaenoic acid metabolism and signaling in iPLA(2)β (VIA)-deficient mice | |
A mathematical model for vasogenic brain edema | |
A PET study of Turner's syndrome: effects of sex steroids and the X chromosome on brain. | |
Time-course and regional distribution of the metabolic effects of bromocriptine in the rat brain | |
[Timely diagnosis of stomach cancer under ambulatory conditions] | |
Topiramate does not alter the kinetics of arachidonic or docosahexaenoic acid in brain phospholipids of the unanesthetized rat. | |
Topographical analysis of glucose metabolism, as measured with positron emission tomography, in dementia of the Alzheimer type: use of linear histograms | |
Tracking of Alzheimer's disease progression with cerebrospinal fluid tau protein phosphorylated at threonine 231. | |
Transfer of 45Ca and 36Cl at the blood-nerve barrier of the sciatic nerve in rats fed low or high calcium diets | |
Transient postnatal fluoxetine leads to decreased brain arachidonic acid metabolism and cytochrome P450 4A in adult mice | |
Transport properties of vertebrate blood-nerve barrier: comparison with blood-brain barrier | |
[Tuberculosis of the gallbladder: clinico-ultrasonographic diagnosis] | |
Ulceretive esophagitis as a precancerous disease (according to cytological data) | |
Upregulated expression of brain enzymatic markers of arachidonic and docosahexaenoic acid metabolism in a rat model of the metabolic syndrome | |
Upregulated liver conversion of alpha-linolenic acid to docosahexaenoic acid in rats on a 15 week n-3 PUFA-deficient diet | |
Use of a computer in an endoscopic unit | |
Utilization of plasma fatty acid in rat brain: distribution of [14C]palmitate between oxidative and synthetic pathways | |
Valnoctamide, a non-teratogenic amide derivative of valproic acid, inhibits arachidonic acid activation in vitro by recombinant acyl-CoA synthetase-4 | |
Valnoctamide, which reduces rat brain arachidonic acid turnover, is a potential non-teratogenic valproate substitute to treat bipolar disorder. | |
Valproic acid down‐regulates the conversion of arachidonic acid to eicosanoids via cyclooxygenase‐1 and ‐2 in rat brain | |
Valproic acid selectively inhibits conversion of arachidonic acid to arachidonoyl-CoA by brain microsomal long-chain fatty acyl-CoA synthetases: relevance to bipolar disorder | |
Valproyl-CoA and esterified valproic acid are not found in brains of rats treated with valproic acid, but the brain concentrations of CoA and acetyl-CoA are altered | |
[Value of studying pure pancreatic juice in the diagnosis of diseases of the pancreas | |
Vascular dementia: how to make the diagnosis in office practice | |
Vascular dementia: stroke prevention takes on new urgency | |
Who may be interested?] |